Physician Interpretation of Data of Uncertain Clinical Utility in Oncology Prescription Drug Promotion.

ABSTRACT:

Background

Little is known about how physicians interpret data displays that depict preliminary or exploratory clinical data in physician-targeted sales aids for oncology drugs. Using three factorial experiments, we examined whether disclosures of data limitations and clinical uncertainty adequately communicate the limitations and practical utility of this type of data.

Subjects, materials, and methods

The studies used a 2 (disclosure of data limitations: technical, nontechnical) × 2 (disclosure of clinical uncertainty: present, absent) + 1 (control: no disclosure) between-subjects experimental design to examine the impact of disclosures as they relate to presentations of preliminary or exploratory data in promotional communications for oncology products. In each experiment,

SUBMITTER: Boudewyns V 

PROVIDER: S-EPMC8649057 | biostudies-literature | 2021 Dec

REPOSITORIES: biostudies-literature